Shandong Weigao Orthopaedic Device Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000050W9
CNY
28.15
0.23 (0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
444.26
285.98
363.83
328.53
397.50
344.79
197.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
444.26
285.98
363.83
328.53
397.50
344.79
197.93
Raw Material Cost
149.87
112.49
121.11
119.14
135.67
148.13
91.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.02
0.04
0.82
0.07
0.00
0.16
0.64
Selling and Distribution Expenses
149.76
95.33
136.24
107.24
164.52
142.05
103.65
Other Expenses
2.67
2.58
2.53
2.49
3.15
2.67
3.98
Total Expenditure (Excl Depreciation)
326.37
233.63
283.52
251.31
331.66
317.06
235.32
Operating Profit (PBDIT) excl Other Income
117.89999999999999
52.400000000000006
80.3
77.2
65.8
27.7
-37.400000000000006
Other Income
13.12
16.28
18.66
11.39
16.40
14.10
18.00
Operating Profit (PBDIT)
131.15
94.65
99.45
116.09
97.88
69.32
16.13
Interest
0.02
0.04
0.82
0.07
0.00
0.16
0.64
Exceptional Items
1.07
0.22
-0.01
0.09
0.00
0.00
0.13
Gross Profit (PBDT)
294.38
173.49
242.72
209.39
261.83
196.65
106.71
Depreciation
26.08
26.08
27.74
27.74
27.68
27.68
26.93
Profit Before Tax
106.12
68.76
70.88
88.38
70.20
41.48
-11.31
Tax
14.04
16.21
11.03
16.12
9.88
5.63
-2.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
90.17
51.79
59.46
71.16
58.22
34.91
-9.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
90.17
51.79
59.46
71.16
58.22
34.91
-9.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.92
0.76
0.40
1.09
2.09
0.95
0.91
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
92.08
52.55
59.86
72.26
60.32
35.85
-8.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,036.04
4,005.31
3,953.52
3,913.93
3,893.09
3,882.86
3,868.92
Earnings per share (EPS)
0.23
0.13
0.15
0.18
0.15
0.09
-0.02
Diluted Earnings per share
0.23
0.13
0.15
0.18
0.15
0.09
-0.02
Operating Profit Margin (Excl OI)
20.7%
18.29%
14.58%
23.43%
13.53%
7.99%
-14.55%
Gross Profit Margin
29.76%
33.16%
27.11%
35.34%
24.62%
20.06%
7.89%
PAT Margin
20.3%
18.11%
16.34%
21.66%
14.65%
10.12%
-4.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 11.77% vs -2.93% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 52.74% vs 246.55% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 44.79% vs 107.91% in Jun 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Shandong Weigao Orthopaedic Device Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
444.26
0
444.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
444.26
0
444.26
Raw Material Cost
149.87
0
149.87
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.02
0
0.02
Selling and Distribution Expenses
149.76
0
149.76
Other Expenses
2.67
0.00
2.67
Total Expenditure (Excl Depreciation)
326.37
0
326.37
Operating Profit (PBDIT) excl Other Income
117.89
0.00
117.89
Other Income
13.12
0
13.12
Operating Profit (PBDIT)
131.15
0
131.15
Interest
0.02
0
0.02
Exceptional Items
1.07
0
1.07
Gross Profit (PBDT)
294.38
0
294.38
Depreciation
26.08
0
26.08
Profit Before Tax
106.12
0
106.12
Tax
14.04
0
14.04
Provisions and contingencies
0
0
0.00
Profit After Tax
90.17
0
90.17
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
90.17
0
90.17
Share in Profit of Associates
0
0
0.00
Minority Interest
1.92
0
1.92
Other related items
0.00
0.00
0.00
Consolidated Net Profit
92.08
0
92.08
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,036.04
0
4,036.04
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
20.70%
0%
0.00
20.70%
Gross Profit Margin
29.76%
0%
0.00
29.76%
PAT Margin
20.30%
0%
0.00
20.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 44.43 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 55.35% vs -21.39% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.77% vs -2.93% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.21 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 75.43% vs -12.35% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 52.74% vs 246.55% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 50.51% vs -2.97% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 44.79% vs 107.91% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.70%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024